Skip to main content
[Preprint]. 2023 Sep 25:rs.3.rs-3356170. [Version 1] doi: 10.21203/rs.3.rs-3356170/v1

Figure 1.

Figure 1

Sampling collection data through time and lung function response to ETI treatment among participants. A) Schematic of longitudinal samples collected for this study. Each black line represents a sample collection day. Black arrows represent the day in which subjects started on ETI treatment. B) Lung function variation for highest ppFEV1% predicted pre- and post-ETI treatment per subject on each group and the absolute delta variation in the change in ppFEV1% predicted per subject post-ETI treatment within each group. The significance was determined through DM t-test and Welch’s t-test respectively. C) Lung function as ppFEV1% predicted of individual subjects through time (days) before and after ETI. Colors represent the treatment status (pre- and post-ETI) in which lung function was recorded and its corresponding significance (T-test) between the two different periods.